TABLE 1.
Baseline Characteristics (N = 1,475)
| Age at time of MI, yrs | 45 (41–48) |
|
| |
| Female | 294 (19.9) |
|
| |
| White | 1,060 (71.9) |
|
| |
| ST-segment elevation myocardial infarction | 846 (57.4) |
|
| |
| Diabetes | 246 (16.7) |
|
| |
| Hypertension | 649 (44.0) |
|
| |
| Dyslipidemia | 818 (55.5) |
|
| |
| Current smoking | 772 (52.3) |
|
| |
| Former smoker | 196 (13.2) |
|
| |
| Premature CAD in first-degree relative | 424 (28.7) |
|
| |
| Obesity | 437 (29.6) |
|
| |
| Total cholesterol, mg/dl | 191.3 ± 55.9 |
|
| |
| HDL cholesterol, mg/dl | 37.0 ± 10.6 |
|
| |
| LDL cholesterol, mg/dl | 118.4 ± 45.9 |
|
| |
| Triglycerides, mg/dl | 145 (101–17) |
|
| |
| ASCVD score | 4.8 (2.8–8.0) |
|
| |
| ASCVD risk score | |
| <5% | 770 (52.2) |
| 5–7.5% | 298 (20.2) |
| 7.5–20% | 365 (24.7) |
| >20% | 42 (2.8) |
|
| |
| Recommended/considered for statin therapy by 2013 ACC/AHA | 724 (49.1) |
|
| |
| Recommended/considered for statin therapy by 2016 USPSTF | 430 (29.2) |
|
| |
| Recommended/considered for statin therapy by either guideline | 742 (50.3) |
|
| |
| Recommended/considered for statin therapy by NCEP III | 507 (34.4) |
Values are median (interquartile range), n (%), or mean ± SD.
ACC/AHA = American College of Cardiology/American Heart Association; ASCVD = atherosclerotic cardiovascular disease; CAD = coronary artery disease; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MI = myocardial infarction; NCEP = National Cholesterol Education Panel; USPSTF = U.S. Preventive Services Task Force.